When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KALA - Bausch Health announces publication of late-stage study results for loteprednol etabonate ophthalmic gel
Kala Pharmaceuticals Inc.
Results from a Phase 3 clinical trial evaluating Bausch Health Companies' (BHC-1.7%) loteprednol etabonate ophthalmic gel, 0.38% for the treatment of postoperative pain and inflammation following eye surgery were just published in the Journal of Cataract and Refractive Surgery.
More news on: Bausch Health Companies Inc., Kala Pharmaceuticals, Healthcare stocks news,